See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899923_2022_Myriad_Genetics_INC.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.3433038749150238, 'aggregate_val': 790400000, 'exp_sum': 588400000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 514700000, 'ResearchAndDevelopmentExpense': 85400000, 'remainder_Expenses': -11700000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.3023255813953488, 'aggregate_val': 851200000, 'exp_sum': 653600000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 537800000, 'ResearchAndDevelopmentExpense': 81900000, 'remainder_Expenses': 33900000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000899923, Myriad Genetics INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 84,900,000 |
| 1 | LiabilitiesCurrent | 240,100,000 |
| 2 | remainder_Liabilities | 27,900,000 |
| 3 | AssetsCurrent | 484,800,000 |
| 4 | AssetsNoncurrent | 149,100,000 |
| 5 | PropertyPlantAndEquipmentNet | 43,500,000 |
| 6 | Goodwill | 643,300,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 537,800,000 |
| 9 | ResearchAndDevelopmentExpense | 81,900,000 |
| 10 | remainder_Expenses | 231,500,000 |
| 11 | remainder_Revenues | 690,600,000 |
| 12 | remainder_NetIncome | 133,400,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,800,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 352,900,000 |
| 1 | Assets | 1,320,700,000 |
| 2 | Expenses | 851,200,000 |
| 3 | Revenues | 690,600,000 |
| 4 | StockholdersEquity | 967,800,000 |
| 5 | NetIncome | -27,200,000 |
| 6 | ComprehensiveNetIncome | -28,600,000 |
| 7 | BaseVar | 1,675,800,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.55 |
| 9 | EconomicCapitalRatio | 2.05 |